QA: Lisata Therapeutics INC in us_health_services/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000320017_2024_Lisata_Therapeutics_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000320017, Lisata Therapeutics INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 332,000
2 AssetsCurrent 53,924,000
3 PropertyPlantAndEquipment 175,000
4 remainder_Assets 263,000
5 LongTermLiabilities 210,000
6 LiabilitiesCurrent 6,590,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 12,974,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 0
16 remainder_Expenses 10,404,000
17 remainder_Revenues 0
18 remainder_NetIncome 2,538,000
19 remainder_ComprehensiveNetIncome -13,000
  yvar yval
0 Assets 54,694,000
1 Liabilities 6,800,000
2 Expenses 23,378,000
3 Revenues 0
4 StockholdersEquity 47,894,000
5 NetIncome -20,840,000
6 ComprehensiveNetIncome -20,853,000
7 BaseVar 43,711,500
8 EconomicCapitalRatio 3.65

Edgar->Model Mapping

Feature Distribution

Change over Time